CAR T cell-mediated production of IFN-γ with target antigen-positive non-Ph-like and Ph-like ALL cell line (eg, CD19+/TSLPR- NALM-6, CD19+/TSLPR+MUTZ5, CD19+/TSLPR- TVA-1 [49]) co-incubation was also analogously suppressed in the presence of concomitant dasatinib or ruxolitinib compared to no TKI exposure (Supplementary Fig. 7C). The gene discussed is CD19; the disease is acute lymphoblastic leukemia.